Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter … Read more
Procter & Gamble Health Limited (PGHL) - Total Assets
Latest total assets as of September 2025: ₹8.94 Billion INR
Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) holds total assets worth ₹8.94 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Procter & Gamble Health Limited - Total Assets Trend (2003–2024)
This chart illustrates how Procter & Gamble Health Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Procter & Gamble Health Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Procter & Gamble Health Limited's total assets of ₹8.94 Billion consist of 66.3% current assets and 33.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹898.10 Million | 23.7% |
| Accounts Receivable | ₹1.47 Billion | 18.5% |
| Inventory | ₹1.09 Billion | 13.8% |
| Property, Plant & Equipment | ₹1.22 Billion | 15.4% |
| Intangible Assets | ₹7.10 Million | 0.1% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Procter & Gamble Health Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Procter & Gamble Health Limited's current assets represent 66.3% of total assets in 2024, an increase from 48.6% in 2003.
- Cash Position: Cash and equivalents constituted 23.7% of total assets in 2024, up from 0.3% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 18.5% of total assets.
Procter & Gamble Health Limited Competitors by Total Assets
Key competitors of Procter & Gamble Health Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Procter & Gamble Health Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Procter & Gamble Health Limited generates 1.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Procter & Gamble Health Limited generates $ 31.63 in net profit.
Procter & Gamble Health Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.87 | 3.35 | 3.59 |
| Quick Ratio | 2.30 | 2.79 | 2.65 |
| Cash Ratio | 1.26 | 0.00 | 0.00 |
| Working Capital | ₹4.17 Billion | ₹ 5.41 Billion | ₹ 4.24 Billion |
Procter & Gamble Health Limited - Advanced Valuation Insights
This section examines the relationship between Procter & Gamble Health Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.09 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | ₹7.94 Billion |
| Market Capitalization | $450.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values Procter & Gamble Health Limited's assets below their book value (0.06 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Procter & Gamble Health Limited's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Procter & Gamble Health Limited (2003–2024)
The table below shows the annual total assets of Procter & Gamble Health Limited from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₹7.94 Billion | -0.02% |
| 2023-12-31 | ₹7.94 Billion | -27.86% |
| 2022-12-31 | ₹11.01 Billion | +23.21% |
| 2021-12-31 | ₹8.94 Billion | -9.37% |
| 2020-12-31 | ₹9.86 Billion | -16.17% |
| 2019-12-31 | ₹11.76 Billion | -33.14% |
| 2018-12-31 | ₹17.59 Billion | +77.50% |
| 2017-12-31 | ₹9.91 Billion | +12.28% |
| 2016-12-31 | ₹8.83 Billion | +12.61% |
| 2015-12-31 | ₹7.84 Billion | +10.70% |
| 2014-12-31 | ₹7.08 Billion | +9.19% |
| 2013-12-31 | ₹6.49 Billion | +9.14% |
| 2012-12-31 | ₹5.94 Billion | +18.94% |
| 2011-12-31 | ₹5.00 Billion | +16.20% |
| 2010-12-31 | ₹4.30 Billion | -24.32% |
| 2009-12-31 | ₹5.68 Billion | +1.36% |
| 2008-12-31 | ₹5.61 Billion | +14.50% |
| 2007-12-31 | ₹4.90 Billion | +2.12% |
| 2006-12-31 | ₹4.79 Billion | +23.73% |
| 2005-12-31 | ₹3.87 Billion | +18.48% |
| 2004-12-31 | ₹3.27 Billion | +17.60% |
| 2003-12-31 | ₹2.78 Billion | -- |